Join the club for FREE to access the whole archive and other member benefits.

Danny Sullivan

Contributing editor to Longevity Technology

Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Details last updated 10-Feb-2020

Articles written by Danny Sullivan

Immortal Dragons has launched with $40 million to support longevity research

Immortal Dragons has launched with $40 million to support longevity research

Longevity Technology - 18-Jul-2025

The fund bridges East-West collaboration and acts quickly using its own capital

Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies

Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies

Longevity Technology - 15-Jul-2025

New investment fuels development of therapies targeting mtDNA-related energy disorders

Epigenica debuts scalable tech to track epigenetic ageing

Epigenica debuts scalable tech to track epigenetic ageing

Longevity Technology - 04-Jul-2025

Epigenica launches scalable tech to decode epigenetic ageing and disease markers

Outsee raises 1.8m for AI genomics in drug discovery

Outsee raises 1.8m for AI genomics in drug discovery

Longevity Technology - 25-Jun-2025

Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets

Infinity Bio raises $8m to decode the antibody reactome

Infinity Bio raises $8m to decode the antibody reactome

Longevity Technology - 24-Jun-2025

Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing

Parallel Bio raises $21m to replace animal testing with human immune organoids

Parallel Bio raises $21m to replace animal testing with human immune organoids

Longevity Technology - 17-Jun-2025

New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models

Juvena strikes $650m deal with lilly to tackle obesity

Juvena strikes $650m deal with lilly to tackle obesity

Longevity Technology - 11-Jun-2025

AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss

AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition

AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition

Longevity Technology - 05-Jun-2025

Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

Longevity Technology - 30-May-2025

Biotech firm uses AI and robotics to test drugs on real human tissues, not animals

Neuralink raised $600 million, reaching a $9 billion valuation

Neuralink raised $600 million, reaching a $9 billion valuation

Longevity Technology - 28-May-2025

The company is still in early stages but attracting strong investor interest

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Longevity Technology - 23-May-2025

Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy

AI startup Somite raises $47m to revolutionize stem cell therapy

AI startup Somite raises $47m to revolutionize stem cell therapy

Longevity Technology - 16-May-2025

Somite AI uses DeltaStem to speed up and scale stem cell engineering

BrightFocus Foundation fuels early research on aging diseases with $13m grants

BrightFocus Foundation fuels early research on aging diseases with $13m grants

Longevity Technology - 13-May-2025

Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Longevity Technology - 12-May-2025

Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states

Hundred health acquires BellSant to supercharge AI longevity platform  strapline:

Hundred health acquires BellSant to supercharge AI longevity platform strapline:

Longevity Technology - 08-May-2025

AI-driven health platform gears up for launch with cutting-edge longevity data

NewLimit secures $130m to accelerate epigenetic reprogramming for longevity

NewLimit secures $130m to accelerate epigenetic reprogramming for longevity

Longevity Technology - 06-May-2025

The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan

Breakthrough drug targets liver regeneration with 21.5m boost

Breakthrough drug targets liver regeneration with 21.5m boost

Longevity Technology - 17-Apr-2025

HepaRegeniX advances trials for a novel liver regeneration therapy

Science corp secures major funding to restore sight with BCI tech

Science corp secures major funding to restore sight with BCI tech

Longevity Technology - 15-Apr-2025

A next-gen retinal implant offers new hope for vision loss from macular degeneration

New drug for Parkinson’s may keep symptoms under control with just weekly injections

New drug for Parkinson’s may keep symptoms under control with just weekly injections

Longevity Technology - 09-Apr-2025

It avoids common delivery problems and enters Phase 1 trials in 2025

Tribune Therapeutics secures 37m to tackle fibrosis at its source

Tribune Therapeutics secures 37m to tackle fibrosis at its source

Longevity Technology - 28-Mar-2025

Scandinavian biotech targets fibrosis with novel scar-blocking therapies


Display all articles